Outcomes of Discontinuing Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcomes of Discontinuing Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation

Published:2013-02 Issue:6 Volume:61 Page:651-658
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Patel Manesh R.,Hellkamp Anne S.,Lokhnygina Yuliya,Piccini Jonathan P.,Zhang Zhongxin,Mohanty Surya,Singer Daniel E.,Hacke Werner,Breithardt Günter,Halperin Jonathan L.,Hankey Graeme J.,Becker Richard C.,Nessel Christopher C.,Berkowitz Scott D.,Califf Robert M.,Fox Keith A.A.,Mahaffey Kenneth W.

Funder

Astra Zeneca

Johnson & Johnson

Janssen Pharmaceuticals

BI

Bayer

Lilly

Boehringer

AstraZeneca

Boehringer Ingelheim

Bristol Myers-Squibb

Daiichi Sankyo

Eli Lilly

GlaxoSmithKline

Merck

Novartis

Sanofi

Pozen

Regado

Schering-Plough

The Medicines Company

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference8 articles.

1. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis;Hart;Ann Intern Med,1999

2. Warfarin discontinuation after starting warfarin for atrial fibrillation;Fang;Circ Cardiovasc Qual Outcomes,2010

3. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation;Hylek;Circulation,2007

4. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011

5. Rivaroxaban-Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study;Am Heart J,2010

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Managing the Patient on Antiplatelet, Anticoagulation, Beta Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin-Receptors Blockers: The Anesthesia Perspective;Principles of Perioperative Safety and Efficiency;2024

2. Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non‐valvular atrial fibrillation;Pharmacoepidemiology and Drug Safety;2023-11-27

3. Minimal Adherence Threshold to Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation to Reduce the Risk of Thromboembolism and Death: A Nationwide Cohort Study;Cardiovascular Drugs and Therapy;2023-09-14

4. Platelets and Their Role in Hemostasis and Thrombosis—From Physiology to Pathophysiology and Therapeutic Implications;International Journal of Molecular Sciences;2022-10-23

5. Anticoagulant therapy for the prevention of recurrent stroke in patients with atrial fibrillation: a comprehensive risk management;Cardiovascular Therapy and Prevention;2022-01-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3